Transduction of ovarian cancer cells: A recombinant adeno-associated viral vector compared to an adenoviral vector

British Journal of Cancer

Volumn 85, Issue 10, 2001, Pages 1592-1599

  Vermeij, J ^a   Zeinoun, Z ^a   Neyns, B ^a   Teugels, E ^a   Bourgain, C ^a   De Greve J ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Cancer gene therapy; Ovarian cancer; Recombinant adeno associated virus; Recombinant adenovirus

Indexed keywords

RECOMBINANT PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CONTROLLED STUDY; GENE AMPLIFICATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; TITRIMETRY;

ADENOVIRIDAE; CARCINOMA; DEPENDOVIRUS; DNA, RECOMBINANT; DNA, VIRAL; FEMALE; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OVARIAN NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035900824     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2082     Document Type: Article

References (32)

1. Adeno-associated parvoviruses inhibit growth of cells derived from malignant human tumors
2. Gene therapy and ovarian cancer: A review
3. Interaction of adeno-associated virus rep78 with p53: Implications in growth inhibition
4. Evaluation of VP22 spread in tissue culture
5. Highly purified adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
6. "Dot Blot" hybridization of labeled probe to DNA or RNA samples
7. Second strand synthesis is a rate limiting step for efficient transduction by recombinant adeno-associated virus vectors
8. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading strand synthesis
9. High titer ade no-associated viral vectors from a rep/cap cell line and hybrid shuttle virus
10. Novel tools for production and purification of recombinant adeno-associated virus vectors
11. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: Recent advances and potential clinical applications
12. A simplified system for generating recombinant adenoviruses
13. Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2
14. The use of recombinant adeno-associated viral vector for transduction of epithelial tumor cells
15. Inhibition of cellular transformation by the adeno-associated virus rep gene
16. Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells
17. Is green fluorescent protein toxic to the living cells
18. Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: Evidence for high transduction efficiency into primary epithelial cancer cells
19. Adeno-associated virus type 2 mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase and gene expression
20. An adenovirus type 5 mutant with the preterminal protein gene deleted efficiently provides helper functions for the production of recombinant adeno-associated virus
21. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): In vitro and in vivo effects of genotoxic agents
22. Role of the tyrosine phosphorylation of a cellular protein in adeno-associated virus mediated gene transfer
23. Adeno-associated virus type 2 mediated gene transfer: Correlation of tyrosine phophorelation of the cellular single stranded D sequence binding protein with transgene expression in human cells in vitro and murine tissues in vivo
24. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
25. Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene
26. The tumor suppressive properties of adeno-associated viruses
27. Adeno-associated virus type 2 nonstructural protein Rep 78 suppresses translation in vitro
28. A new strategy for large-scale preparation of high titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography
29. Cellular contaminants of adeno-associated virus vector stocks can enhance transduction
30. Superior gene transfer into solid tumor cells than into human mobilized peripheral blood progenitor cells using helpervirus free adeno-associated viral vector stocks
31. Adeno-associated virus sensitizes HeLa cell tumors to gamma rays
32. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells